Barriere G, Pelloquin-Mvogo Z, Boulain M, Khsime I, Bharatiya R, Riquier M
Int J Mol Sci. 2025; 26(5).
PMID: 40076918
PMC: 11901079.
DOI: 10.3390/ijms26052298.
Hinz M, Stein A, Cole T
Clin Pharmacol. 2014; 6:189-94.
PMID: 25484598
PMC: 4238750.
DOI: 10.2147/CPAA.S72234.
Hinz M, Stein A, Cole T
Clin Pharmacol. 2014; 6:161-9.
PMID: 25364278
PMC: 4211847.
DOI: 10.2147/CPAA.S70707.
Hinz M, Stein A, Uncini T
Neuropsychiatr Dis Treat. 2012; 8:323-8.
PMID: 22888252
PMC: 3415362.
DOI: 10.2147/NDT.S33259.
Morgan R, Parry A, Arida R, Matthews P, Davies B, Castell L
Psychopharmacology (Berl). 2006; 190(3):383-9.
PMID: 17180619
DOI: 10.1007/s00213-006-0609-7.
Potentiation of DOI-induced forward locomotion in rats by (-)-pindolol pretreatment.
Kaur P, Ahlenius S
J Neural Transm (Vienna). 1997; 104(6-7):605-14.
PMID: 9444561
DOI: 10.1007/BF01291879.
The effect of IV L-tryptophan on prolactin, growth hormone, and mood in healthy subjects.
Charney D, Heninger G, Reinhard Jr J, Sternberg D, Hafstead K
Psychopharmacology (Berl). 1982; 78(1):38-43.
PMID: 6815695
DOI: 10.1007/BF00470585.
The effect of intravenous L-tryptophan on prolactin and growth hormone and mood in healthy subjects.
Charney D, Heninger G, Reinhard Jr J, Sternberg D, Hafstead K
Psychopharmacology (Berl). 1982; 77(3):217-22.
PMID: 6812143
DOI: 10.1007/BF00464569.
Discriminative stimulus properties of L-5-hydroxytryptophan: behavioral evidence for multiple serotonin receptors.
Barrett R, Blackshear M, Sanders-Bush E
Psychopharmacology (Berl). 1982; 76(1):29-35.
PMID: 6805004
DOI: 10.1007/BF00430750.
Effect of 5,7-dihydroxytryptamine on serotonergic control of prolactin secretion and behavior in rats.
Kuhn C, Vogel R, Mailman R, Mueller R, Schanberg S, Breese G
Psychopharmacology (Berl). 1981; 73(2):188-93.
PMID: 6785814
DOI: 10.1007/BF00429216.
The influence of probenecid on the metabolism of serotonin, dopamine and their precursors in man.
van Praag H, Flentge F, Korf J, Dols L, SCHUT T
Psychopharmacologia. 1973; 33(2):141-51.
PMID: 4775879
DOI: 10.1007/BF00429084.
[Brain amines and apomorphine-induced intraspecific aggressive behavior in the rat (author's transl)].
SENAULT B
Psychopharmacologia. 1974; 34(2):143-54.
PMID: 4274176
DOI: 10.1007/BF00421939.
Evidence for the functional interaction of two central neurotransmitters.
Jacobs B
Psychopharmacologia. 1974; 39(1):81-6.
PMID: 4153732
DOI: 10.1007/BF00421461.
Antagonism by ketanserin of the behavioral effects of quipazine but not l-5-hydroxytryptophan in squirrel monkeys.
Witkin J, Brady L, Barrett J
Psychopharmacology (Berl). 1988; 94(3):302-5.
PMID: 3128804
DOI: 10.1007/BF00174679.
Responses of prolactin and growth hormone to L-tryptophan infusion: effects in normal subjects and schizophrenic patients receiving neuroleptics.
Cowen P, Gadhvi H, Gosden B, KOLAKOWSKA T
Psychopharmacology (Berl). 1985; 86(1-2):164-9.
PMID: 2991963
DOI: 10.1007/BF00431703.
Norepinephrine and serotonin: specificity of release with rewarding electrical stimulation of the brain.
Holloway J
Psychopharmacologia. 1975; 42(2):127-34.
PMID: 1161973
DOI: 10.1007/BF00429542.
On the interaction of 5-hydroxytryptophan and 5-hydroxytryptamine with dopamine metabolism in the rat striatum.
Awazi N, Guldberg H
Naunyn Schmiedebergs Arch Pharmacol. 1978; 303(1):63-72.
PMID: 307696
DOI: 10.1007/BF00496186.
The actions of dihydroxyphenylalanine and dihydroxyphenylserine on the sleep-wakefulness cycle of the rat after peripheral decarboxylase inhibition.
Altier H, Moldes M, Monti J
Br J Pharmacol. 1975; 54(1):101-6.
PMID: 166716
PMC: 1666399.
DOI: 10.1111/j.1476-5381.1975.tb07415.x.
Effects of drugs acting on cerebral 5-hydroxytryptamine mechanisms on dopamine-dependent turning behaviour in mice.
Milson J, Pycock C
Br J Pharmacol. 1976; 56(1):77-85.
PMID: 130178
PMC: 1666754.
DOI: 10.1111/j.1476-5381.1976.tb06961.x.
